candesartan has been researched along with Atrial Remodeling in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Atrial Remodeling: Long-term changes in the electrophysiological parameters and/or anatomical structures of the HEART ATRIA that result from prolonged changes in atrial rate, often associated with ATRIAL FIBRILLATION or long periods of intense EXERCISE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with candesartan had no influence on serum YKL-40 levels." | 2.78 | Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. ( Arnesen, H; Seljeflot, I; Smith, P; Svendsen, JH; Tveit, A, 2013) |
| "Treatment with candesartan completely abrogated the emergence of the enlarged cells but did not reverse the Ito, and IKur in normal-sized cells in DCM hearts." | 1.40 | Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice. ( Daida, H; Inoue, H; Konishi, M; Kurebayashi, N; Morimoto, S; Murayama, T; Nakazato, Y; Odagiri, F; Sakurai, T; Shioya, T; Sugihara, M; Suzuki, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tveit, A | 1 |
| Seljeflot, I | 1 |
| Smith, P | 1 |
| Arnesen, H | 1 |
| Svendsen, JH | 1 |
| Odagiri, F | 1 |
| Inoue, H | 1 |
| Sugihara, M | 1 |
| Suzuki, T | 1 |
| Murayama, T | 1 |
| Shioya, T | 1 |
| Konishi, M | 1 |
| Nakazato, Y | 1 |
| Daida, H | 1 |
| Sakurai, T | 1 |
| Morimoto, S | 1 |
| Kurebayashi, N | 1 |
1 trial available for candesartan and Atrial Remodeling
| Article | Year |
|---|---|
Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
Topics: Adipokines; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Atrial Fibrillation; Atrial R | 2013 |
1 other study available for candesartan and Atrial Remodeling
| Article | Year |
|---|---|
Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice.
Topics: Angiotensin Receptor Antagonists; Animals; Atrial Remodeling; Benzimidazoles; Biphenyl Compounds; Ca | 2014 |